Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials
- PMID: 39775309
- PMCID: PMC11684688
- DOI: 10.1371/journal.pone.0316871
Correction: Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0307800.].
Copyright: © 2024 Kusuma et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Erratum for
-
Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials.PLoS One. 2024 Aug 12;19(8):e0307800. doi: 10.1371/journal.pone.0307800. eCollection 2024. PLoS One. 2024. PMID: 39133693 Free PMC article.
References
-
- Kusuma F, Glenardi G, Mangkuliguna G, Winarto H, Purwoto G, Utami TW, et al.. (2024) Efficacy, safety, and patient-reported outcome of immune checkpoint inhibitor in gynecologic cancers: A systematic review and meta-analysis of randomized controlled trials. PLOS ONE 19(8): e0307800. doi: 10.1371/journal.pone.0307800 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
